ClearArc Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-37,387
Closed -$3.68M 409
2018
Q3
$3.68M Buy
37,387
+261
+0.7% +$24.1K 0.48% 55
2018
Q2
$3.18M Buy
37,126
+44
+0.1% +$3.67K 0.45% 60
2018
Q1
$2.98M Buy
37,082
+149
+0.4% +$12.3K 0.45% 57
2017
Q4
$2.98M Sell
36,933
-367
-1% -$29.4K 0.41% 66
2017
Q3
$2.9M Buy
37,300
+1,119
+3% +$92.9K 0.44% 61
2017
Q2
$3.21M Buy
36,181
+1,316
+4% +$111K 0.52% 50
2017
Q1
$2.81M Sell
34,865
-6,953
-17% -$543K 0.47% 56
2016
Q4
$2.98M Sell
41,818
-22,111
-35% -$1.74M 0.54% 47
2016
Q3
$5.52M Buy
63,929
+1,633
+3% +$142K 1.04% 20
2016
Q2
$5.41M Buy
62,296
+18,925
+44% +$1.53M 1.05% 20
2016
Q1
$3.25M Buy
43,371
+1,853
+4% +$140K 0.69% 36
2015
Q4
$3.19M Sell
41,518
-325
-0.8% -$24.5K 0.67% 35
2015
Q3
$2.8M Buy
41,843
+677
+2% +$49.9K 0.58% 40
2015
Q2
$3.05M Buy
41,166
+8,353
+25% +$638K 0.56% 45
2015
Q1
$2.56M Buy
32,813
+9,919
+43% +$752K 0.52% 48
2014
Q4
$1.65M Buy
22,894
+766
+3% +$53.2K 0.34% 88
2014
Q3
$1.37M Sell
22,128
-963
-4% -$61.2K 0.31% 88
2014
Q2
$1.47M Buy
23,091
+213
+0.9% +$12.9K 0.34% 89
2014
Q1
$1.41M Buy
22,878
+1,425
+7% +$83K 0.35% 79
2013
Q4
$1.23M Buy
21,453
+1,208
+6% +$68.5K 0.32% 92
2013
Q3
$1.08M Buy
20,245
+818
+4% +$44K 0.3% 95
2013
Q2
$1M Buy
+19,427
New +$960K 0.27% 111

Other funds holding MDT

ClearArc Capital's MDT Position: Q4 2018 in Review

ClearArc Capital sold out of Medtronic (MDT) in Q4 2018, closing a stake of 37,387 shares — an estimated $3.68M sold.

ClearArc Capital first reported a position in MDT in Q2 2013 and held it in 22 quarters. The position peaked at $5.52M in Q3 2016. 1,564 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • ClearArc Capital reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • ClearArc Capital sold 37,387 Medtronic shares in Q4 2018, an estimated $3.68M.
  • ClearArc Capital first reported a position in Medtronic in Q2 2013 and held it in 22 quarters.
  • ClearArc Capital's Medtronic position peaked at $5.52M in Q3 2016.
  • 1,564 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on ClearArc Capital's 13F filing for Q4 2018, filed 14 Feb 2019.